Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated Kinases-Reference-Cited by-同舟云学术

Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated Kinases

Published:2003-04 Issue:14 Volume:278 Page:12151-12156
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Fujino Hiromichi,Xu Wei,Regan John W.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference30 articles.

1. Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype.

2. Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype

3. Prostanoid receptor heterogeneity through alternative mRNA splicing

4. Phosphorylation of Glycogen Synthase Kinase-3 and Stimulation of T-cell Factor Signaling following Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The signaling pathway through which Procyanidin B2 increases the activity of the Na+/K+ ATPase in Caco-2 cells;Journal of Functional Foods;2024-08

2. Prostaglandin E2 may clinically alleviate dry eye disease by inducing Th17 cell differentiation;Chemical Biology & Drug Design;2024-02

3. Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment;Frontiers in Pharmacology;2023-08-17

4. Single hormone or synthetic agonist induces G _s /G _i coupling selectivity of EP receptors via distinct binding modes and propagating paths;Proceedings of the National Academy of Sciences;2023-07-21

5. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategies;Clinical and Translational Oncology;2023-03-10